ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 797

Absolute Reduction of Peripheral CD4+ Regulatory T Cells in Patients with Systemic Sclerosis and Its Restoration By Short-Term and Low Dose IL-2 Treatment

Lili Shang1, Jing Luo2, Chong Gao3, Jingman Yuan1, Qian Li1, Xiaoli Liu1, Huiying Gao1 and Xiao-Feng Li4, 1Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China, 2the Second Hospital of Shanxi Medical University, Taiyuan, China, 3Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA, 4Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: regulatory cells and systemic sclerosis, T cells

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of the present study was to investigate whether the imbalance of CD4+ T subsets can be corrected by supplementing low dose interleukin -2 (IL-2).

Methods: The PB samples from 21 patients with SSc as well as 30 healthy control subjects were analyzed for lymphocyte subsets using flow cytometry. Patients given a small dose of IL-2 (50WIU) for a 5-day course based on standard treatment (including glucocorticoids, immunosuppressants, biologics, or combination). Using directly the percentages from flow cytometry combined with internal standard beads calculated absolute number of peripheral lymphocyte subsets and their ratio to Treg cells from the subjects in each group before and after IL-2 treatment.

Results: Notably, Treg cells rapidly increase after treatment with low doses IL-2. However, before treatment, the ratios of Th17/Treg(p<0.001) and Th2/Treg£¨p=0.01£©were significantly higher. After treatment, although Th17 and Th2 cells increased, Treg cells increased more, so the ratios returned to normal. Similarly, after treatment, the numbers of Th1, CD8+ T, NK and B cells all increased to some extent, but the ratios of these T cells to Treg cells still were low i.e. they were balanced for the increase in Treg cells after treatment was more pronounced.

Conclusion:Short-term low-dose IL-2 treatment can promote the proliferation of Treg cells mainly and restore the balances of various cell subsets with Treg cells.


Disclosure: L. Shang, None; J. Luo, None; C. Gao, None; J. Yuan, None; Q. Li, None; X. Liu, None; H. Gao, None; X. F. Li, None.

To cite this abstract in AMA style:

Shang L, Luo J, Gao C, Yuan J, Li Q, Liu X, Gao H, Li XF. Absolute Reduction of Peripheral CD4+ Regulatory T Cells in Patients with Systemic Sclerosis and Its Restoration By Short-Term and Low Dose IL-2 Treatment [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/absolute-reduction-of-peripheral-cd4-regulatory-t-cells-in-patients-with-systemic-sclerosis-and-its-restoration-by-short-term-and-low-dose-il-2-treatment/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2018

ACR Meeting Abstracts - https://acrabstracts.org/abstract/absolute-reduction-of-peripheral-cd4-regulatory-t-cells-in-patients-with-systemic-sclerosis-and-its-restoration-by-short-term-and-low-dose-il-2-treatment/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology